Our dedicated team at Monash Gastroenterology endeavour to provide the highest quality treatment to patients with HCC through coordinated care from diagnosis, treatment and clinical follow-up.
Referred cases of suspected or confirmed HCC are first reviewed at a fortnightly multidisciplinary team (MDT) meeting. This group includes Radiologists, Gastroenterologists, Surgeons, Oncologists, Radiation Oncologists, Palliative care team, and HCC Clinical Nurse Specialists.
Following review of imaging scans and clinical information, the MDT then recommends the optimal management for each case based on current national (GESA) and international guidelines (EASL & AASLD). The treatment options include liver transplantation, surgical resection, locoregional therapy such as microwave ablation (MWA) or transarterial chemoembolization (TACE), radiotherapy and supportive care. Enrollment in current clinical trials is also offered to patients that are within eligibility criteria.
External referrals to our HCC service can be submitted to the Monash Gastroenterology Department by your GP or specialist and internal referrals can be submitted electronically on SMR.
